DLA Piper's Life Sciences Index: Innovation and Growth

DLA Piper
70 Rue aux Laines
1000 Brussels
Belgium

DLA Piper’s award-winning Life Sciences team will shortly be publishing its Life Sciences Index, a first-of-its-kind study series that examines and tracks perceptions of innovation and growth in the life sciences sector.

We surveyed 200 industry leaders from the world’s top biopharma and medtech companies and asked for their insights on the market environment for incentivising innovation and growth, dealmaking, sustainability and ESG, intelligent technology and the future of care delivery. The result is a comprehensive state of the market report, intended to be published every two years, that we hope will spark debate and discussion at our exclusive roundtable lunch event in Brussels on Tuesday, 11 June.

We look forward to seeing you there!